Work

Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Hepatology

DOI: 10.1016/j.jhep.2024.12.006

Authors: Lin Xiang, Guixia Wang, Yulei Zhuang, Lin Luo, Jiangyu Yan, Hong Zhang, Xiaojiao Li, Can Xie, Qingwei He, Yuyu Peng, Hong Chen, Qianqian Li, Xiaoping Li, Linfeng Guo, Guoyue Lv, Yanhua Ding

Institutions: First Hospital of Jilin University, HEC Pharm (China)

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China

Awards: G1122983988, G7970508018

OpenAlex ID: W4405592007

FWCI: 8.93

Cites: 38

Cited by: 54

Related to: 10